Michael Birrer on Predicting Outcomes in Ovarian Cancer

Michael Birrer, MD, PhD, Harvard Medical School, discusses what he hopes to discover as factors that influence long-term survival in patients and survivors with ovarian cancer.

Michael Birrer, MD, PhD, Harvard Medical School, discusses what he hopes to discover as factors that may influence long-term survival in patients and survivors of ovarian cancer.

Birrer is involved in a study examining psychosocial, quality of life, and genomic factors at diagnosis that correlate with survival lasting longer than 10 years. Hopefully, he says, this will lead to more personalized medicine so that every patient with ovarian cancer can become a long-term survivor.